NCT05081531View on ClinicalTrials.gov

AI for Head Neck Cancer Treated With Adaptive RadioTherapy (RadiomicART)

NAActive, not recruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

October 5, 2021

Primary Completion Date

October 1, 2025

Study Completion Date

October 1, 2025

Conditions
Head and Neck Cancer
Interventions
RADIATION

Adaptive Radiotherapy

All the patients will be treated with VMAT technique in its RapidArc form. A simultaneous integrated boost (SIB) technique will be used. The GTV will encompass the tumor delineated on CT scan, adjusted for MRI and PET scans. Patients will be treated with a total dose of 66 Gy, 60 Gy and 54 Gy on PTV1, PTV2 and PTV3, respectively, delivered in 30 fractions, 5 fractions per week.

Trial Locations (1)

20089

Humanitas Clinical institute, Rozzano

All Listed Sponsors
lead

Istituto Clinico Humanitas

OTHER